Ho Won Seo

624 total citations
29 papers, 547 citations indexed

About

Ho Won Seo is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Ho Won Seo has authored 29 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Ho Won Seo's work include Cardiac Ischemia and Reperfusion (9 papers), Cardiac electrophysiology and arrhythmias (7 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (4 papers). Ho Won Seo is often cited by papers focused on Cardiac Ischemia and Reperfusion (9 papers), Cardiac electrophysiology and arrhythmias (7 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (4 papers). Ho Won Seo collaborates with scholars based in South Korea, India and United States. Ho Won Seo's co-authors include Byung Ho Lee, Kwang‐Seok Oh, Kyu Yang Yi, Jeong Hyun Lee, Shi Yong Ryu, Sung‐Eun Yoo, Young Sup Kim, Sukhyang Lee, Chae Jo Lim and Hyun‐Na Koo and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Ho Won Seo

29 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ho Won Seo South Korea	17	220	95	84	82	78	29	547
Mukesh Nandave India	18	269 1.2×	64 0.7×	105 1.3×	74 0.9×	71 0.9×	52	848
A. H. M. Thippeswamy India	12	113 0.5×	87 0.9×	61 0.7×	111 1.4×	158 2.0×	20	630
Jianguo Xing China	15	347 1.6×	156 1.6×	84 1.0×	50 0.6×	53 0.7×	32	800
Yi Qu China	8	162 0.7×	65 0.7×	79 0.9×	63 0.8×	29 0.4×	13	402
Reem N. El‐Naga Egypt	18	251 1.1×	54 0.6×	187 2.2×	77 0.9×	43 0.6×	32	792
Mohamed A. El‐Moselhy Egypt	19	294 1.3×	92 1.0×	103 1.2×	137 1.7×	33 0.4×	39	975
Nanjaian Mahadevan India	17	230 1.0×	61 0.6×	65 0.8×	113 1.4×	30 0.4×	37	814
Prahalathan Pichavaram United States	16	274 1.2×	51 0.5×	39 0.5×	50 0.6×	28 0.4×	26	686
Tarique Anwer Saudi Arabia	18	191 0.9×	57 0.6×	138 1.6×	151 1.8×	136 1.7×	45	839
Yiqun Tang China	15	319 1.4×	61 0.6×	38 0.5×	159 1.9×	45 0.6×	35	620

Countries citing papers authored by Ho Won Seo

Since Specialization

Citations

This map shows the geographic impact of Ho Won Seo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ho Won Seo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ho Won Seo more than expected).

Fields of papers citing papers by Ho Won Seo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ho Won Seo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ho Won Seo. The network helps show where Ho Won Seo may publish in the future.

Co-authorship network of co-authors of Ho Won Seo

This figure shows the co-authorship network connecting the top 25 collaborators of Ho Won Seo. A scholar is included among the top collaborators of Ho Won Seo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ho Won Seo. Ho Won Seo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Seo, Ho Won, Ji Young Hyun, Hwan Jung Lim, et al.. (2024). NUAK2 Inhibitors, KHKI-01128 and KHKI-01215, Exhibit Potent Anticancer Activity Against SW480 Colorectal Cancer Cells. Anticancer Research. 44(7). 2909–2919. 3 indexed citations

Lee, Jeong Hyun, et al.. (2021). KR-31831 improves survival and protects hematopoietic cells and radiosensitive tissues against radiation-induced injuries in mice. Biomedicine & Pharmacotherapy. 146. 112350–112350. 4 indexed citations

Lee, Ju‐Hee, et al.. (2019). Icariin protects against radiation-induced mortality and damage in vitro and in vivo. International Journal of Radiation Biology. 95(8). 1094–1102. 11 indexed citations

Lee, Jeong Hyun, Sung Bum Park, Haushabhau S. Pagire, et al.. (2019). Optimization of cyclic sulfamide derivatives as 11β-hydroxysteroid dehydrogenase 1 inhibitors for the potential treatment of ischemic brain injury. Bioorganic & Medicinal Chemistry Letters. 30(2). 126787–126787. 8 indexed citations

Lee, Jeong Hyun, Kwang‐Seok Oh, Kyu Yang Yi, et al.. (2016). A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension. International Immunopharmacology. 40. 196–202. 23 indexed citations

Lim, Chae Jo, Kwang‐Seok Oh, Jae Du Ha, et al.. (2014). 4-Substituted quinazoline derivatives as novel EphA2 receptor tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(17). 4080–4083. 18 indexed citations

Oh, Kwang‐Seok, Ho Won Seo, Nam Sook Kang, et al.. (2013). Cardiovascular effects of a novel selective Rho kinase inhibitor, 2-(1H-indazole-5-yl)amino-4-methoxy-6-piperazino triazine (DW1865). European Journal of Pharmacology. 702(1-3). 218–226. 30 indexed citations

Cho, Sung Yun, Byung Ho Lee, Heejung Jung, et al.. (2013). Design and synthesis of novel 3-(benzo[d]oxazol-2-yl)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine derivatives as selective G-protein-coupled receptor kinase-2 and -5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(24). 6711–6716. 17 indexed citations

Oh, Kwang‐Seok, et al.. (2011). Salvianolic acid A suppress lipopolysaccharide-induced NF-κB signaling pathway by targeting IKKβ. International Immunopharmacology. 11(11). 1901–1906. 60 indexed citations

10.

Seo, Ho Won, et al.. (2010). Euonymus alatus extract attenuates LPS-induced NF-κB activation via IKKβ inhibition in RAW 264.7 cells. Journal of Ethnopharmacology. 134(2). 288–293. 18 indexed citations

11.

Oh, Kwang‐Seok, et al.. (2009). Melanin-concentrating hormone-1 receptor antagonism and anti-obesity effects of ethanolic extract from Morus alba leaves in diet-induced obese mice. Journal of Ethnopharmacology. 122(2). 216–220. 56 indexed citations

12.

Oh, Kwang‐Seok, Sukhyang Lee, Kyu Yang Yi, et al.. (2008). A Novel and Orally Active Poly(ADP-Ribose) Polymerase Inhibitor, KR-33889 [2-[Methoxycarbonyl(4-methoxyphenyl) methylsulfanyl]-1 H-benzimidazole-4-carboxylic Acid Amide], Attenuates Injury in in Vitro Model of Cell Death and in Vivo Model of Cardiac Ischemia. Journal of Pharmacology and Experimental Therapeutics. 328(1). 10–18. 19 indexed citations

13.

Oh, Kwang‐Seok, Ho Won Seo, Kyu Yang Yi, et al.. (2007). Effects of KR‐33028, a novel Na⁺/H⁺ exchanger‐1 inhibitor, on ischemia and reperfusion‐induced myocardial infarction in rats and dogs. Fundamental and Clinical Pharmacology. 21(3). 255–263. 8 indexed citations

14.

Oh, Kwang‐Seok, Jung Won Lee, Ho Won Seo, et al.. (2006). Vasorelaxant effect of stilbenes from rhizome extract of rhubarb (Rheum undulatum) on the contractility of rat aorta. Phytotherapy Research. 21(2). 186–189. 34 indexed citations

15.

Lee, Byung Ho, et al.. (2005). Effects of KR-32570, a new Na+/H+ exchanger inhibitor, on functional and metabolic impairments produced by global ischemia and reperfusion in the perfused rat heart. European Journal of Pharmacology. 511(2-3). 175–182. 17 indexed citations

16.

Lee, Byung Ho, et al.. (2004). Antihypertensive Effect of Amlodipine Adipate, a Novel Salt of Amlodipine, in Hypertensive Rat Models. Biomolecules & Therapeutics. 12(1). 19–24. 1 indexed citations

17.

Lee, Byung Ho, Ho Won Seo, & Sung‐Eun Yoo. (2003). Cardioprotective Effects of (2S,3R,4S)-N’-Benzyl-N’’-Cyano-N-(3,4-Dihydro-2-Dimethoxymethyl-3-Hydroxy-2-Methyl-6-Nitro-2H-Benzopyran-4-yl)-Guanidine (KR-31372) in Rats and Dogs. Pharmacology. 70(2). 74–82. 21 indexed citations

18.

Lee, Sukhyang, Kyu Yang Yi, Soo‐Kyung Kim, et al.. (2003). Cardioselective anti-ischemic ATP-sensitive potassium channel (KATP) openers: benzopyranyl indoline and indole analogues. European Journal of Medicinal Chemistry. 38(5). 459–471. 26 indexed citations

19.

Lee, Byung Ho, et al.. (1999). In Vivo Pharmacologic Profile of SK-1080, an Orally Active Nonpeptide AT1-Receptor Antagonist. Journal of Cardiovascular Pharmacology. 33(3). 375–382. 10 indexed citations

20.

Seo, Ho Won, et al.. (1998). Cardiovascular Pharmacology of SKP-450, a New Potassium Channel Activator, and Its Major Metabolites SKP-818 and SKP-310. Pharmacology. 56(3). 111–124. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact